These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 10428665)
21. [The relationship between cell membrane adrenoreceptor response and insulinemia in hypertension patients undergoing calcium antagonist treatment]. Dlusskaia IG; Striuk RI; Bobrovnitskiĭ IP; Petrova TV Eksp Klin Farmakol; 1995; 58(6):49-51. PubMed ID: 8704614 [TBL] [Abstract][Full Text] [Related]
22. [Resp-informations]. Bouvier-Colle MH; Cot M; Le Goaster C Rev Epidemiol Sante Publique; 2000 Apr; 48(2):215-24. PubMed ID: 10804430 [No Abstract] [Full Text] [Related]
23. When hypertension and diabetes coexist: strategies for cardiorenal protection. Weber MA Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536 [TBL] [Abstract][Full Text] [Related]
24. Calcium antagonists for antihypertensive baseline therapy. First International Nitrendipine Symposium. Interlaken, April 13-14, 1984. J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S929-1113. PubMed ID: 6085378 [No Abstract] [Full Text] [Related]
25. Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial. Staessen JA; Thijs L; Gasowski J; Cells H; Fagard RH Am J Cardiol; 1998 Nov; 82(9B):20R-22R. PubMed ID: 9822139 [TBL] [Abstract][Full Text] [Related]
26. Controlling hypertension in patients with diabetes. Konzem SL; Devore VS; Bauer DW Am Fam Physician; 2002 Oct; 66(7):1209-14. PubMed ID: 12387432 [TBL] [Abstract][Full Text] [Related]
27. Changing concepts in the management of hypertension: the role of effective and prompt blood pressure reduction. Berbari AE; Khayat A; Daouk N; Daouk M J Med Liban; 2008; 56(4):226-9. PubMed ID: 19115597 [No Abstract] [Full Text] [Related]
28. From Tritace to Tri-Plen - the South African journey. Cardiovasc J Afr; 2009; 20(1):69-70. PubMed ID: 19287820 [No Abstract] [Full Text] [Related]
29. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors. Rollins G Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699 [No Abstract] [Full Text] [Related]
30. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life]. Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634 [TBL] [Abstract][Full Text] [Related]
31. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
32. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade. Weir MR J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800 [TBL] [Abstract][Full Text] [Related]
33. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721 [TBL] [Abstract][Full Text] [Related]
34. [Calcium channel blockers and cardiovascular morbidity mortality]. Robles NR An Med Interna; 1997 May; 14(5):217-9. PubMed ID: 9235095 [No Abstract] [Full Text] [Related]
36. Treatment of hypertension in patients with diabetes mellitus. Agarwal R Indian Heart J; 2001; 53(3):361-9. PubMed ID: 11516043 [No Abstract] [Full Text] [Related]
38. Hypertension in an urban population--who is treated with what and how well? Li C; Hedblad B; Berglund G; Janzon L J Hum Hypertens; 2007 Apr; 21(4):323-6. PubMed ID: 17273156 [No Abstract] [Full Text] [Related]